Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: Results from a longitudinal study

Lung

Volumn 191, Issue 5, 2013, Pages 501-509

  Van Herk Sukel, Myrthe P P ^a   Shantakumar, Sumitra ^b   Penning Van Beest, Fernie J A ^a   Kamphuisen, Pieter W ^c   Majoor, Christof J ^d   Overbeek, Lucy I H ^e   Herings, Ron M C ^a,f  

^a PHARMO INSTITUTE FOR DRUG OUTCOMES RESEARCH   (Netherlands)

^b GLAXOSMITHKLINE   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e PALGA Foundation   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Ischemic stroke; Myocardial infarction; Non small cell lung cancer; Pulmonary embolism; Risk; Small cell lung cancer

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ERLOTINIB; ETOPOSIDE; GEMCITABINE; PACLITAXEL;

AGED; ARTICLE; BRAIN ISCHEMIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURGERY; CONTROLLED STUDY; DRUG USE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; LONGITUDINAL STUDY; LUNG CANCER; LUNG EMBOLISM; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; DRUG THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; LUNG NEOPLASMS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; PNEUMONECTOMY; PULMONARY EMBOLISM; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE;

EID: 84884812327     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9485-1     Document Type: Article

References (37)

1. Buller HR, van Doormaal FF, van Sluis GL, Kamphuisen PW (2007) Cancer and thrombosis: from molecular mechanisms to clinical presentations. J Thromb Haemost 5(Suppl 1):246-254
2. Khorana AA (2009) Cancer and thrombosis: implications of published guidelines for clinical practice. Ann Oncol 20:1619-1630
3. Prandoni P, Falanga A, Piccioli A (2005) Cancer and venous thromboembolism. Lancet Oncol 6:401-410
4. Khorana AA, Connolly GC (2009) Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol 27:4839-4847
5. Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients. Cancer 110:2339-2346
6. Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE (2006) Incidence of venous thromboembolism in patients hospitalized with cancer. Am J Med 119:60-68
7. Chew HK, Wun T, Harvey D, Zhou H, White RH (2006) Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 166:458-464
8. Kuderer NM, Ortel TL, Francis CW (2009) Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol 27:4902-4911
9. Zangari M, Fink LM, Elice F, Zhan F, Adcock DM, Tricot GJ (2009) Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 27:4865-4873
10. Cronin-Fenton DP, Sondergaard F, Pedersen LA, Fryzek JP, Cetin K, Acquavella J, Baron JA, Sorensen HT (2010) Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer 103:947-953. doi: 10.1038/sj.bjc.6605883
11. Corrales-Rodriguez L, Blais N (2012) Lung cancer associated venous thromboembolic disease: a comprehensive review. Lung Cancer 1-8. 10.1016/j.lungcan.2011.07.004
12. Chew HK, Davies AM, Wun T, Harvey D, Zhou H, White RH (2008) The incidence of venous thromboembolism among patients with primary lung cancer. J Thromb Haemost 6:601-608. doi: 10.1111/j.1538-7836.2008.02908.x
13. Tagalakis V, Levi D, Agulnik JS, Cohen V, Kasymjanova G, Small D (2007) High risk of deep vein thrombosis in patients with non-small cell lung cancer: a cohort study of 493 patients. J Thorac Oncol 2:729-734. doi: 10.1097/JTO.0b013e31811ea275
14. Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH (2006) Thromboembolism in hospitalized neutropenic cancer patients. J Clin Oncol 24:484-490
15. Blom JW, Osanto S, Rosendaal FR (2004) The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2:1760-1765. doi: 10.1111/j.1538-7836.2004.00928.x
16. Chen PC, Muo CH, Lee YT, Yu YH, Sung FC (2011) Lung cancer and incidence of stroke: a population-based cohort study. Stroke 42:3034-3039. doi: 10.1161/strokeaha.111.615534
17. Casparie M, Tiebosch AT, Burger G, Blauwgeers H, van de Pol A, van Krieken JH, Meijer GA (2007) Pathology databanking and biobanking in The Netherlands, a central role for PALGA, The Nationwide Histopathology and Cytopathology Data Network and Archive. Cell Oncol 29:19-24
18. Dezentje VO, van Blijderveen NJ, Gelderblom H, Putter H, van Herk-Sukel MP, Casparie MK, Egberts AC, Nortier JW, Guchelaar HJ (2010) Effect of concomitant CYP2D6 inhibitor use and tamoxifen adherence on breast cancer recurrence in early-stage breast cancer. J Clin Oncol 28:2423-2429
19. Koomen ER, Joosse A, Herings RM, Casparie MK, Guchelaar HJ, Nijsten T (2009) Does use of estrogens decrease the Breslow thickness of melanoma of the skin? Oral contraceptives and hormonal replacement therapy. Melanoma Res 19:327-332
20. Accessed 7 Feb 2013
21. Horlander KT, Mannino DM, Leeper KV (2003) Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med 163:1711-1717
22. So L, Evans D, Quan H (2006) ICD-10 coding algorithms for defining comorbidities of acute myocardial infarction. BMC Health Serv Res 6:161
23. Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR (2008) Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 17:20-26
24. Breslow NE, Day NE (1989) Statistical methods in cancer research, vol II: the design and analysis of cohort studies. IARC Scientific Publications No. 82, Lyon, pp 69-72
25. Blom JW, Vanderschoot JP, Oostindier MJ, Osanto S, van der Meer FJ, Rosendaal FR (2006) Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost 4:529-535
26. White RH, Chew HK, Zhou H, Parikh-Patel A, Harris D, Harvey D, Wun T (2005) Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 165:1782-1787
27. van Herk-Sukel MP, Shantakumar S, Kamphuisen PW, Penning-van Beest FJ, Herings RM (2011) Myocardial infarction, ischaemic stroke and pulmonary embolism before and after breast cancer hospitalisation. A population-based study. Thromb Haemost 106:149-155. doi: 10.1160/TH10-12-0778
28. Piccioli A, Prandoni P (2001) Venous thromboembolism as first manifestation of cancer. Acta Haematol 106:13-17
29. Otten HM, Prins MH (2001) Venous thromboembolism and occult malignancy. Thromb Res 102:V187-V194
30. Tesselaar ME, Osanto S (2007) Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 13:362-367. doi: 10.1097/MCP.0b013e328209413c
31. Statistics on cancer in the Netherlands as registered in the Netherlands Cancer Registry (2013). http://www.cijfersoverkanker.nl/. Accessed 7 Feb 2013
32. Dutch Guideline "Small cell lung cancer" (2011) Association of Comprehensive Cancer Centres, Version 1.0
33. Dutch Guideline "Non-small cell lung cancer" (2011) Association of Comprehensive Cancer Centres, Version 2.0
34. van Meerbeeck JP, Fennell DA, De Ruysscher DK (2011) Small-cell lung cancer. Lancet 378:1741-1755. doi: 10.1016/S0140-6736(11)60165-7
35. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr (1994) The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 154:861-866
36. Wolinsky FD, Wan GJ, Gurney JG, Bentley DW (1998) The risk of hospitalization for ischemic stroke among older adults. Med Care 36:449-461
37. Zidane M, van Hulsteijn LH, Brenninkmeijer BJ, Huisman MV (2006) Out of hospital treatment with subcutaneous low molecular weight heparin in patients with acute deep-vein thrombosis: a prospective study in daily practice. Haematologica 91:1052-1058